SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 104.69   5.42 (+5.46%) Volume: 849k 4:00 PM EDT Sep 19, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
8-KReport of unscheduled material events or corporate changes.406/19/2018
4Statement of changes in beneficial ownership of securities106/04/2018
DEFA14AAdditional proxy soliciting materials - definitive1106/04/2018
PRER14AProxy soliciting materials. Revised preliminary material705/23/2018
8-KReport of unscheduled material events or corporate changes.35205/22/2018
CT ORDER105/22/2018
8-KReport of unscheduled material events or corporate changes.905/18/2018
4Statement of changes in beneficial ownership of securities105/15/2018
2345678910111213141516